Furthermore, a recent study revealed that FcεRI is expressed in BDCA1+ DCs in human arthritic synovial fluid and malignant tumor ascites [15], and additionally demonstrated that FcεRI is a useful marker that distinguishes DCs from macrophages, which do not express FcεRI but do express mannose receptors and DC-SIGN [15]. Here, CD209 is linked to cancer.